Key result
Higher frailty scores, assessed by the Addenbrookes Vascular Frailty Score, significantly predicted 3-year mortality in patients undergoing lower limb surgical revascularization (AUROC 0.724; 95% CI 0.654-0.794; P=0.0001).
Why the study?
Frailty is a marker of poor outcome in vascular surgery, presenting challenges for patients with lower limb peripheral arterial disease requiring surgical revascularization, but its impact in this group using a specialty specific frailty score needed assessment.
Does frailty assessed by AVFS and LAVFS predict 3-year mortality in patients undergoing lower limb open surgical revascularization for chronic limb ischemia?
Cohort (n=261)
Does frailty assessed by AVFS and LAVFS predict 3-year mortality in patients undergoing lower limb open surgical revascularization for chronic limb ischemia?
Incremental worsening of frailty, determined using specialty-specific frailty scores (AVFS and LAVFS), predicts 3-year mortality risk in patients undergoing lower limb surgical revascularization.
Answers are grounded in this paper and cite their sources.
Frailty screening may refine perioperative risk counseling in PAD revascularization; leaves open whether interventions modify outcomes.
BACKGROUND: Frailty in vascular surgery patients is increasingly recognized as a marker of poor outcome. This provides particular challenges for patients with lower limb peripheral arterial disease who require surgical revascularization. This study aimed to assess the impact of frailty on short- and long-term outcome in this specific patient group using a specialty specific frailty score. METHODS: Patients undergoing open surgical revascularization for chronic limb ischemia (January 2015-December 2016) were assessed. Demographics, mode of admission, diagnosis, and site of surgery were recorded alongside a variety of frailty-specific characteristics. We calculated the previously validated Addenbrookes Vascular Frailty Score (AVFS) and Long AVFS (LAVFS). Primary outcome was 3-year mortality. RESULTS: Two hundred and sixty-one patients (75% men, median age 69 years) were studied. The median length of stay was 6 days with a 3-year mortality of 23%. The predictive power of vascular frailty scores showed that for 3-year mortality, area under the receiver operator curve values (AUROC) were specific for both the AVFS score (AUROC: 0.724, 95% CI: 0.654-0.794) and LAVFS Score (AUROC: 0.741, 95%CI: 0.670-0.813). Furthermore, the cumulative AVFS and LAVFS scores both predicted mortality over the follow-up period (P=0.0001) with increased mortality among patients with higher scores. CONCLUSIONS: Incremental worsening of frailty, determined using a specialty specific frailty score, predicts mortality risk in patients undergoing lower limb surgical revascularization.
No takes yet. Share an insight, caveat, or question.
Kalyanasundaram et al. (2022) conducted a cohort in Chronic limb ischemia requiring open surgical revascularization (n=261). Frailty (Addenbrookes Vascular Frailty Score and Long AVFS) was evaluated on 3-year mortality (AUROC 0.724, 95% CI 0.654-0.794, p=0.0001). Higher frailty scores, assessed by the Addenbrookes Vascular Frailty Score, significantly predicted 3-year mortality in patients undergoing lower limb surgical revascularization (AUROC 0.724; 95% CI 0.654-0.794; P=0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: